T. Nakamura et al., Effects of fosfomycin and imipenem-cilastatin on the nephrotoxicity of vancomycin and cisplatin in rats, J PHARM PHA, 51(2), 1999, pp. 227-232
The nephrotoxicity of vancomycin and cisplatin and the protective effects o
f fosfomycin and imipenem-cilastalin on renal function have been studied in
rats. The renal clearance of vancomycin after the induction of renal dysfu
nction was also evaluated by calculating the glomerular filtration rate (GF
R) and its secretary clearance.
Plasma concentrations of creatinine and urea nitrogen increased dose-depend
ently after vancomycin injection. No such increases were observed after co-
treatment with fosfomycin or imipenem-cilastatin. Changes of N-acetyl-beta-
D-glucosaminidase activity in the urine of vancomycin-treated rats were not
remarkable compared with those in cisplatin-treated animals. The reduced r
enal clearance of vancomycin in rats with acute renal failure induced by va
ncomycin was because of a decrease in both GFR and secretory clearance. How
ever, the changes in GFR and secretory clearance were not proportional-the
change in GFR was more pronounced than that of secretory clearance in the e
xperimental groups, In addition, the renal clearance of vancomycin was main
tained at the control level after coadministration of fosfomycin or imipene
m-cilastatin with vancomycin.
These results suggest that vancomycin impairs glomerular filtration more ma
rkedly than renal tubular function as compared with cisplatin. Co-administr
ation with fosfomycin or imipenem-cilastatin confers significant protection
against the nephrotoxic effects of vancomycin.